Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Caribou Biosciences Q4 EPS $(0.39) Misses $(0.37) Estimate, Sales $3.56M Miss $4.61M Estimate

Author: Happy Mohamed | March 11, 2024 04:22pm
Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.37) by 5.41 percent. This is a 11.36 percent increase over losses of $(0.44) per share from the same period last year. The company reported quarterly sales of $3.56 million which missed the analyst consensus estimate of $4.61 million by 22.82 percent. This is a 3.63 percent decrease over sales of $3.69 million the same period last year.

Posted In: CRBU


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist